drugset / Trial / NCT06097468
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
Phase 1/2
Recruiting
40 enrolled
University of California, San Francisco
National Cancer Institute (NCI) · collabUniversity of California, Los Angeles · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a study of oral nisin administration in patients with OSCC who are undergoing complete surgical resection surgery with or without adjuvant radiation/chemoradiation as part of their routine care at the University of California, San Francisco (UCSF).
Timeline
- Start
- 2024-02-02
- Primary completion
- 2028-03-01
- Completion
- 2028-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NisinZ® P | Unknown | 20000 mg | Oral |